Parallel artificial membrane permeability assay: A new membrane for the fast prediction of passive human skin permeability

Journal of Medicinal Chemistry

Volumn 49, Issue 13, 2006, Pages 3948-3954

  Ottaviani, Giorgio ^a   Martel, Sophie ^a   Carrupt, Pierre Alain ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 NITROPHENOL; 2 NAPHTHOL; 4 NITROPHENOL; ATRAZINE; BENZYL NICOTINATE; CAFFEINE; DEXAMETHASONE; DIMETHYL SULFOXIDE; EPHEDRINE; HYDROCORTISONE; INDOMETACIN; ISOQUINOLINE; KETOPROFEN; LIDOCAINE; MYRISTIC ACID ISOPROPYL ESTER; NAPROXEN; NICOTINE; NICOTINIC ACID METHYL ESTER; NITROPHENOL; PHENAZONE; PHENOBARBITAL; PHENOL; PIROXICAM; PROGESTERONE; RESORCINOL; SALICYLIC ACID; SILICONE; TESTOSTERONE; THYMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; CORRELATION ANALYSIS; DIFFUSION COEFFICIENT; DRUG PENETRATION; PARTITION COEFFICIENT; SKIN PERMEABILITY; STRATUM CORNEUM;

1-OCTANOL; DIFFUSION; DIMETHYLPOLYSILOXANES; HUMANS; MEMBRANES, ARTIFICIAL; MYRISTATES; PERMEABILITY; SKIN; SKIN ABSORPTION; WATER;

EID: 33745642435     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060230+     Document Type: Article

References (52)

1. Hadgraft, J.; Lane, M. E. Skin permeation: the years of enlightenment. Int. J. Pharm. 2005, 305, 2-12.
2. de Jager, M. W.; Gooris, G. S.; Dolbnya, I. P.; Bras, W.; Ponec, M.; Bouwstra, J. A. Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization. J. Lipid Res. 2004, 45, 923-932.
3. Barry, B. W. Dermatological Formulations: Percutaneous Absorption; Dekker: New York, 1983
4. Brain, K. R.; Walters, K. A.; Watkinson, A. C. Methods for studying percutaneous absorption. In Dermatological and Transdermal Formulations; Walters, K. A., Ed.; Marcel Dekker: New York, 2002; pp 197-269.
5. Friend, D. R. In vitro skin permeation techniques. J. Controlled Release 1992, 18, 235-248.
6. Moser, K.; Kriwer, K.; Naik, A.; Kalia, Y. N.; Guy, R. H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Sci. 2001, 52, 103-112.
7. Hadgraft, J.; Ridout, G. Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate. Int. J. Pharm. 1987, 39, 149-156.
8. Hadgraft, J. Skin deep. Eur. J. Pharm. Biopharm. 2004, 58, 291-299.
9. Barry, B. W.; Brace, A. R. Permeation of oestrone, oestradiol, oestriol and dexamethasone across cellulose acetate membrane. J. Pharm. Pharmacol. 1977, 29, 397-400.
10. Barry, B. W.; El Eini, D. I. Influence of non-ionic surfactants on permeation of hydrocortisone, dexamethasone, testosterone and progesterone across cellulose. J. Pharm. Pharmacol. 1976, 28, 219-227.
11. Jetzer, W. E.; Huq, A. S.; Ho, N. F. M.; Flynn, G. L.; Duraiswamy, N.; Condie, L., Jr. Permeation of mouse skin and silicone rubber membranes by phenols: relationship to in vitro partitioning. J. Pharm. Sci. 1986, 75, 1098-1103.
12. Garrett, E. R.; Chemburkar, P. B. Evaluation, control, and prediction of drug diffusion through polymeric membranes. J. Pharm. Sci. 1968, 57, 944-948.
13. Geinoz, S.; Rey, S.; Boss, G.; Bunge, A. L.; Guy, R. H.; Carrupt, P. A.; Reist, M.; Testa, B. Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharm. Res. 2002, 19, 1622-1629.
14. Hadgraft, J.; Ridout, G. Development of model membranes for percutaneous absorption measurements. II. Dipalmitoyl phosphatidylcholine, linoleic acid and tetradecane. Int. J. Pharm. 1988, 42, 97-104.
15. Santi, P.; Catellani, P. L.; Colombo, P.; Ringard-Lefebvre, C.; Barthélémy, C.; Guyot-Hermann, A. M. Partition and transport of verapamil and nicotine through artificial membranes. Int. J. Pharm. 1991, 68, 43-49.
16. Kai, T.; Isami, T.; Kurosaki, Y.; Nakayama, T.; Kimura, T. Keratinized epithelial transport of β-blocking agents. II. Evaluation of barrier property of stratum corneum by using model lipid systems. Biol. Pharm. Bull. 1993, 16, 284-287.
17. Matsuzaki, K.; Imaoka, T.; Asano, M.; Miyajima, K. Development of a model membrane system using startum corneum lipids for estimations of drug skin permeability. Chem. Pharm. Bull. 1993, 41, 575-579.
18. Lovering, E. G.; Black, D. B. Diffusion layer effect on permeation of phenylbutazone through polydimethylsiloxane. J. Pharm. Sci. 1974, 63, 1399-1402.
19. Peck, K. D.; Ghanem, A. H.; Higuchi, W. I. The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane. J. Pharm. Sci. 1985, 84, 975-962.
20. Cordoba-Diaz, M.; Nova, M.; Elorza, B.; Cordoba-Diaz, D.; Chantres, J. R.; Cordoba-Borrego, M. Validation protocol of an automated inline flow-through diffusion equipment for in vitro permeation studies. J. Control. Release 2000, 69, 357-367.
21. Prausnitz, M. R.; Mitragotri, S.; Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discovery 2004, 5, 115-124.
22. Karande, P.; Mitragotri, S. High throughput screening of transdermal formulations. Pharm. Res. 2002, 19, 655-660.
23. Karande, P.; Jain, A.; Mitragotri, Ş. Discovery of transdermal penetration enhancers by high-throughput screening. Nat. Biotechnol. 2004, 22, 192-197.
24. Kansy, M.; Senner, F.; Gubernator, K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 1998, 41, 1007-1010.
25. Wohnsland, F.; Faller, B. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J. Med. Chem. 2001, 44, 923-930.
26. Di, L.; Kerns, E. H.; Fan, K.; McConnell, O. J.; Carter, G. T. High throughput artificial membrane permeability assay for blood-brain barrier. Eur. J. Med. Chem. 2003, 38, 223-232.
27. Maitani, Y.; Shimada, K.; Nagai, T. 1-Menthol, oleic acid and lauricidin in absorption enhancement of free and sodium salt of diclofenac using ethanol treated silicone membrane as model of skin. Chem. Pharm. Bull. 1996, 44, 403-408.
28. Hou, S. Y. E.; Flynn, G. L. Influences of 1-dodecylazacyclophan-2-one on permeation of membranes by weak electrolytes. I. Theoretical analysis of weak electrolyte diffusion through membranes and studies involving silicone rubber membranes. J. Pharm. Sci. 1997, 86, 85-91.
29. Woolfson, A. D.; McCafferty, D. F.; McGowan, K. E. Percutaneous penetration characteristics of amethocaine through porcine and human skin. Int. J. Pharm. 1992, 78, 209-216.
30. Saket, M. M.; James, K. C.; Kellaway, I. W. The partitioning of some 21-alkyl steroid esters between human stratum corneum and water. Int. J. Pharm. 1985, 27, 287-298.
31. Barry, B. W. Dermatological Formulations; Dekker: New York, 1983.
32. Caron, G.; Steyaert, G.; Pagliara, A.; Crivori, P.; Gaillard, P.; Carrupt, P. A.; Avdeef, A.; Box, K. J.; Girault, H. H.; Testa, B. Structure-lipophilicity relationships of the neutral and cationic forms of β-blockers. Part 1. Partitioning in isotropic systems. Helv. Chim. Acta 1999, 82, 1211-1222.
33. a determination of water-insoluble drugs in organic solvent-water mixtures. J. Pharm. Biomed. Anal. 1999, 20, 631-641.
34. Avdeef, A. Absorption and Drug Development; John Wiley & Sons: Hoboken, NJ, 2003.
35. Avdeef, A.; Strafford, M.; Block, E.; Balogh, M. P.; Chambliss, W.; Khan, I. Drug absorption in vitro model: filter-immobilized artificial membranes. Studies of the permeability properties of lactones in piper methysticum forst. Eur. J. Pharm. Sci. 2001, 14, 271-280.
36. Vecchia, B. E.; Bunge, A. Skin absorption databases and predictive equations. In Transdermal Drug Delivery; Guy, R. H., Hadgraft, J., Eds.; Marcel Dekker: New York, 2003; pp 57-141.
37. Faller, B.; Grimm, H. P.; Loeuillet-Ritzler, F.; Arnold, S.; Briand, X. High-throughput lipophilicity measurement with immobilized artificial membranes. J. Med. Chem. 2005, 48, 2571-2576.
38. Johnson, M. E.; Blankschtein, D.; Langer, R. Permeation of steroids through human skin. J. Pharm. Sci. 1995, 84, 1144-1146.
39. Mitragotri, S.; Edwards, D. A.; Blankstein, D.; Langer, R. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J. Pharm. Sci. 1995, 84, 697-706.
40. Abraham, M. H.; Martins, F. Human skin permeation and partition: general linear free-energy relationship analyses. J. Pharm. Sci. 2004, 93, 1508-1523.
41. Johnson, M. E.; Blankstein, D.; Langer, R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J. Pharm. Sci. 1997, 86, 1162-1172.
42. Geinoz, S.; Guy, R. H.; Carrupt, P. A.; Testa, B. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical review. Pharm. Res. 2004, 21, 83-92.
43. Cronin, M. T. D.; Dearden, J. C.; Gupta, R.; Moss, G. P. An investigation of the mechanism of flux across polymethylsiloxane membranes by use of quantitative structure-permeability relationships. J. Pharm. Pharmacol. 1998, 50, 143-152.
44. Potts, R. O.; Guy, R. H. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 1995, 12, 1628-1633.
45. Yourick, J. J.; Koenig, M. L.; Yourick, D. L.; Bronaugh, R. L. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol. Appl. Pharmacol. 2004, 195, 309-320.
46. Williams, F. M. In vitro studies-how good are they at replacing in vivo studies for measurement of skin absorption? Environ. Toxicol. Chem. 2006, 21, 199-203.
47. Bronaugh, R. L.; Hood, H. L. Systemic absorption of cutaneous material. In Topical Absorption of Dermatological Products; Bronaugh, R. L., Maibach, H. I., Eds.; Marcel Dekker: New York, 2002; pp 163-167.
48. Vecchia, B. E.; Bunge, A. L. Partitioning of chemicals into skin: results and predictions. In Transdermal Drug Delivery; Guy, R. H., Hadgraft, J., Eds.; Marcel Dekker: New York, 2003; pp 143-198.
49. Johnson, M. E.; Mitragotri, S.; Patel, A.; Blankschtein, D.; Langer, R. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J. Pharm. Sci. 1996, 85, 670-679.
50. Bouchard, G.; Carrupt, P. A.; Testa, B.; Gobry, V.; Girault, H. H. Lipophilicity and solvation of anionic drugs. Chem.-Eur. J. 2002, 8, 3478-3484.
51. Tsai, R. S.; Carrupt, P. A.; El Tayar, N.; Testa, B.; Giroud, Y.; Andrade, P.; Brée, F.; Tillement, J. P. Physicochemical and structural properties of non-steroidal antiinflammatory oxicams. Helv. Chim. Acta 1993, 76, 842-854.
52. pHalk. J. Med. Chem. 2005, 48, 3269-3279.